Navigation Links
Implanted Defibrillators Benefit Older People
Date:1/6/2009

Improved survival seen in those 75 and older, study says

TUESDAY, Jan. 6 (HealthDay News) -- Implanted cardioverter defibrillators (ICDs), which deliver an electric shock to prevent sudden death when a heart stops beating properly, improve survival in people 75 and older, new research suggests.

The finding contradicts several earlier studies, notably a 2007 report from Canada that said the benefits of ICDs were limited for older people.

"Their discussion looked at defibrillators in patients who were older and sicker," said Dr. Paul Chan, an assistant professor of medicine at the University of Missouri in Kansas City, and lead author of the new report. "It found use of defibrillators was limited, because they were more likely to die. But there was no control group, no comparison with a group of similar patients who did not get defibrillators."

The new study did have such a control group. It looked at results for 500 people who got ICDs because their left ventricles, which pump blood to the body, were functioning at no more than 35 percent of capacity. The study compared those results to those for a similar number of people with the same condition who did not get ICDs.

"We found that older people were more likely to die," Chan said, "but in this older group of patients, we still found they got a benefit from the defibrillator, similar to that seen in the other age groups."

Over the course of the six-year study, the overall death rate was 26.7 percent for the non-ICD group and 21.6 percent for the ICD group. This 30 percent reduction in deaths was the same for people 75 and older as well as younger recipients.

The results, published in the Jan. 7 issue of the journal Circulation: Cardiovascular Quality and Outcomes , indicate that "we shouldn't be denying defibrillators that may be life-saving specifically because of age," Chan said.

He acknowledged that the finding "needs to be validated in other studies with larger populations."

Another factor that must be considered is whether the potential recipient has already experienced a life-threatening heart arrhythmia (irregular heartbeat) or similar event, said Dr. Gordon F. Tomaselli, a professor of medicine at Johns Hopkins University School of Medicine, and a spokesman for the American Heart Association.

"If there has been a life-threatening arrhythmia, and the patient is otherwise healthy, I would be much more inclined to recommend a defibrillator," Tomaselli said. "For primary prevention, when no such event has yet occurred, I would be a lot more cautious about people in their eighth and ninth decades of life, and would carefully consider their comorbidities (more than one illness)".

"Age and comorbidities are the key factors I consider when a patient might require a defibrillator," he said.

More information

Learn more about implanted defibrillators at the American Heart Association.



SOURCES: Paul Chan, M.D., assistant professor of medicine, University of Missouri, Kansas City; Gordon F. Tomaselli, M.D., professor of medicine, Johns Hopkins University School of Medicine, Baltimore; Jan. 7, 2009, Circulation: Cardiovascular Quality and Outcomes


'/>"/>
Copyright©2009 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. New Guidelines Issued for Implanted Heart Devices
2. Test Spots Who Should Get Implanted Defibrillator
3. Study Stresses Importance of Availability of Automated External Defibrillators at Athletic Events
4. $3.5 Million in Reimbursements for Purchases of Automated External Defibrillators (AEDs) for Texas Schools Still Unclaimed With Deadline Approaching
5. MP3 headphones interfere with implantable defibrillators, pacemakers
6. Home Defibrillators Fail to Boost Survival Rates
7. Several methods for enhancing the functioning of defibrillators in cases of heart attack
8. Defibrillators Not Dangerous While Driving
9. Plaintiffs Obtain $240 Million Amended Settlement In Guidant Defibrillators Products Liability Litigation
10. Women Less Likely to Get Heart Defibrillators
11. Universal Benefit Plans and Universal Dental Plan Announce Joint Outreach Initiative to Aid Massachusetts Nonprofits
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/23/2017)... Square, PA (PRWEB) , ... March 23, 2017 , ... ... days. That means many students are thinking about summer internships , which can ... lack thereof). , The pros at Garden Media Group, a boutique public relations firm ...
(Date:3/23/2017)... Jersey (PRWEB) , ... March 23, 2017 , ... ... of herbal-based and non-steroidal skincare products, was awarded as winners of American Dreams ... products. This competition was hosted jointly by HSN and Good Housekeeping. , ...
(Date:3/23/2017)... ... March 23, 2017 , ... News Advisory/Interview Opportunity , After six years of ... victory in Europe for public health and the environment and is calling on the ... research and the overwhelming support of European citizens, the European Union (EU) will, beginning ...
(Date:3/23/2017)... ... March 23, 2017 , ... “A Respectful Response To ... Response To Atheist Manifesto” is the creation of published author Richard Hostetter, a ... sixty years. He holds graduate degrees from Kent State University and the University ...
(Date:3/22/2017)... ... 22, 2017 , ... Cosmetic Town, an online plastic surgery ... companion print magazine. The new magazine, scheduled for release in mid-April, includes articles ... board-certified doctors from across the country. , According to the senior editor of ...
Breaking Medicine News(10 mins):
(Date:3/23/2017)... /PRNewswire/ - Medicure Inc. ("Medicure" or the "Company") ... is pleased to announce that its majority-owned subsidiary, ... U.S. Food and Drug Administration (FDA) for the ... tablets in the 12.5 mg and 25 mg ... equivalent of the branded product Xenazine ® ...
(Date:3/23/2017)... , March 23, 2017 ReNeuron ... its CTX cells in chronic stroke patients, despite not meeting ... primary outcome measure, the Action Research Arm Test (ARAT). As ... to a pivotal controlled clinical study in 2017. Beyond CTX, ... (RP) trial in 2017 and Phase I data from its ...
(Date:3/23/2017)... 2017 The Board of Directors of NeuroVive ... Meeting, which is to take place on Thursday, April 27, 2017, ... Lund, Sweden . ... Please see the attached notification, which is being announced within ... NeuroVive Pharmaceutical AB (Publ) The Board Of Directors About ...
Breaking Medicine Technology: